scispace - formally typeset
K

Kenji Kosaka

Researcher at Yokohama City University

Publications -  274
Citations -  20373

Kenji Kosaka is an academic researcher from Yokohama City University. The author has contributed to research in topics: Dementia with Lewy bodies & Dementia. The author has an hindex of 51, co-authored 274 publications receiving 18520 citations. Previous affiliations of Kenji Kosaka include Hochschule Hannover & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Wortmannin inhibits the activation of MAP kinase following vasopressin V1 receptor stimulation

TL;DR: The results suggest that wortmannin‐sensitive molecules such as PI3‐kinase, are involved in the V1 receptor‐mediated activation of the MAP kinase pathway independent of TPA‐sensitive PKC.
Journal ArticleDOI

SORL1 is Genetically Associated with Neuropathologically Characterized Late-Onset Alzheimer's Disease

TL;DR: This replication study strongly supports the preceding evidence that SORL1 is likely one of the genes associated with LOAD, and strong LD among SNPs was observed within each LD region, implying that there are two genomic regions showing association with LOad in SORl1.
Journal ArticleDOI

Ultrastructural and immunohistochemical study of degenerate neurite-bearing ghost tangles.

TL;DR: Some ghost tangles in the brains of Alzheimer patients were accompanied by many small argyrophilic structures which were electron microscopically confirmed to be degenerate neurites, and may have been induced by the amyloid nature of tubules, which probably provokes the reaction of neuropils.
Journal ArticleDOI

Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia

TL;DR: Dementia with Lewy bodies and Parkinson's disease with dementia were suspected to show cognitive impairment of similar severity in the terminal stage and would thus be difficult to classify as completely different entities.
Journal ArticleDOI

Cyclin-dependent kinase 5 (Cdk5) associated with Lewy bodies in diffuse Lewy body disease.

TL;DR: Investigation of the cyclin-dependent kinase (Cdk) 5 distribution pattern in diffuse Lewy body disease brains using immunohistochemistry suggests that Cdk5 may be associated with LB formation.